Observational Study of the Quality of Life of New Ostomates Using SenSura Mio Appliances With BodyFit Technology
NCT ID: NCT04635215
Last Updated: 2021-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
195 participants
OBSERVATIONAL
2019-02-27
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this context of adapted support, COLOPLAST has developed a range of ostomy pouches, the SenSura Mio BodyFit® technology range, for digestive or urinary stomas. The diversity of the devices makes it possible to find the most suitable combination to adapt to the morphology thanks to an elastic adhesive for a secure fit to individual body shape, and the textile materials used make it possible to optimize wearing comfort.
The aim of this study is to evaluate the quality of life of patients with recent ostomies with one of COLOPLAST's SenSura Mio devices at three months after discharge from the hospital. The condition of the skin around the stoma and the level of satisfaction of the patients will also be evaluated. Finally, the results obtained aim to identify factors predictive of a better quality of life in order to improve management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Performance of Newly Developed 1-piece Ostomy Product Compared With SenSura
NCT01799239
Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece
NCT01957553
Performance Study of Newly Developed Ostomy Products
NCT01513330
Safety and Performance of New 1-piece Ostomy Product
NCT01800916
Comparison Study of 3 Ostomy Products
NCT01691729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
An ostomy is defined by a viscera reaching the skin, outside its natural location, by diversion of the digestive (enterostomy) or urinary (ureterostomy) tract. Digestive ostomies are temporary or permanent palliative surgeries that consist of connecting a segment of the healthy digestive tract to the surface of the skin, either downstream or upstream of a lesion. There are several reasons for this type of stoma: following colorectal cancer or IBD (chronic inflammatory bowel disease), or to decompress and drain the digestive tract in occlusion, or to protect a digestive anastomosis by temporarily diverting the intestinal flow. Urinary ostomies are usually performed following bladder cancer or neurogenic bladder that has resulted in the removal of the bladderr. The urinary tract is then diverted to allow the evacuation of urine into an artificial pouch.
The bodily injury, the creation of a stoma, can have serious familiar, social and professional repercussions. An early follow-up from the preoperative phase and long-term technical and psychological support promote an adaptation of quality. Helping the patient to live well with his disability is a complex task that mobilizes the skills of a multidisciplinary team of caregivers. Mastery of surgical techniques for the creation of ostomies and close collaboration between the surgeon and the stoma therapist are essential for the personalized care of ostomy patients.
Advances in various devices, bag systems and irrigation systems are concrete means that contribute greatly to improving the patient's quality of life. In this context of technological advances, COLOPLAST has developed a range of devices for incontinent digestive and urinary stomas, SenSura Mio Technology BodyFit®. This range of pouches adapts to peristomal morphology and body movements due to an elastic adhesive for a secure fit to individual body shapes. In addition, the pouches are designed to remain discreet and maximize wearing comfort due to a neutral-grey color water-repellent textile material, invisible even under white clothing, and a full-circle prefilter to differ filter saturation for proven reduction of ballooning.
The objective of this study is to evaluate the use of SenSura Mio products in real-life conditions in patients with recent ostomies. For this purpose, we will use the Stoma-QoL specific quality of life scale, as well as the Peristomal Skin Condition Rating Scale (DET Score).
The Stoma-QoL tool was developed and validated specifically for ostomy patients in 2005 at the initiative of COLOPLAST and in close collaboration with international experts, with the aim of evaluating the impact of ostomy related concerns on the quality of life of ostomy patients on the one hand, and improving and facilitating their follow-up on the other hand. Potential items were formulated based on the results of a series of semi-structured interviews conducted with 169 adult subjects who had ostomies for a long time. The process resulted in a preliminary version of 37 items, administered repeatedly to 182 subjects with an ileostomy or colostomy. A psychometric selection of the items was performed using a Rasch model. The Stoma-QOL questionnaire has in its most refined version 20 questions covering 4 domains, not scored independently: sleep, intimate relationships, relationships with family and close friends, and social relationships with other people. This 20-item version has been validated internationally in ileo- or colostomized patients. On average, the value of the overall Stoma-QoL score was 58.5 with the lowest mean value (53.8) observed in France and the highest mean value (62.6) in Denmark. Stoma-QoL can be offered to ostomy patients who have already lived at least 1 month with their stoma and appliance.
The DET Score -also known as the Ostomy Skin Tool- is a measurement tool for assessing the extent and severity of peristomal skin problems. It was developed by Martins et al in 2008, at the initiative of COLOPLAST and in close collaboration with international experts, with the intention of improving the monitoring of peristomal skin conditions in ostomy patients and optimizing communication between healthcare professionals. The DET Score is divided into three areas: Discoloration (D), Erosion (E) and Tissue Proliferation (T). For each area, a maximum of 5 points can be awarded, 3 for the affected area and 2 for severity. The scores for each domain should be based solely on observations of each subject's skin, not on past experience. Photographs of problem skin are included in this rating scale and can be used as a guide for scoring severity. Once the score for each domain has been assessed, a total score is calculated by adding the numbers. A score of 0 represents normal skin while a score of 15 represents maximum skin severity around the stoma. The DET Score was validated in 2011 18: it is now widely used and has been translated into several languages. Skin problems are considered mild if DET Score ≤ 4; moderate if DET Score \< 7; severe if DET Score ≥ 7. The mean value observed in an international study of more than 3,000 ostomy patients was 2.5 (± 2.8).
The objectives of the present study are multiple: to evaluate the quality of life of patients with recent ostomies using SenSura Mio appliances during the first three months following hospital discharge, to evaluate the condition of the peristomal skin during this same period and to look for factors predictive of a better quality of life. The data collected in this study will help to better document the factors influencing the quality of life of French patients with recent ostomies and the value of using the new SenSura Mio appliances. This study will also provide a better understanding of the incidence of skin problems in the early follow-up phase (first three months) and the main corrective actions taken by the ostomy nurses.
The QoL Mio study population will be composed of adults with recent ostomies (stoma preparation \< 1 month), with liquid effluent (right colostomy, ileostomy, jejunostomy or urostomy), for whom healthcare professionals have recommended the use of SenSura Mio devices for ostomy care as part of the routine care. Because liquid effluents can seep under the adhesive on the skin, this population (ostomy with liquid effluents) has a higher risk of peristomal skin damage with irritant dermatitis by contact with corrosive effluents. The BodyFit technology (conforms to folds and irregularities of the skin) of SenSura Mio devices appears to be particularly suitable in this population to preserve the integrity of the peristomal skin.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
There are not multiple groups in this study
Sensura Mio Bodyfit technology ostomy pouches
The use of medical devices, the ostomy pouches from Sensura Mio Bodyfit technology range, will be studied from inclusion visit (less than one month after the beginning of use) and during 3 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sensura Mio Bodyfit technology ostomy pouches
The use of medical devices, the ostomy pouches from Sensura Mio Bodyfit technology range, will be studied from inclusion visit (less than one month after the beginning of use) and during 3 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject who signed the consent form
* Subject affiliated to a social security scheme or entitled to a social security benefit
* Subject with an ostomy less than one month old, with an expected stoma duration \> 3 months
* Subject presenting an enterostomy with liquid effluents (right colostomy, ileostomy, jejunostomy) or a urostomy, user of a high flow or drainable pouch (Uro)
* Subjects for which the healthcare professional decided to use the SenSura Mio Technology BodyFit™ as the first permanent ostomy appliance after surgery as part of the care routines
* Subject educated in ostomy care and who manages it himself in an autonomous or assisted manner.
Exclusion Criteria
* Pregnant, parturient or breastfeeding woman ;
* Subject deprived of liberty by judicial, medical or administrative decision;
* Minor subject;
* Subject legally protected or unable to express consent;
* Subject not affiliated or not benefiting from a social security system;
* Subject falling into several of the above categories;
* Subject who refused to participate in the study; and
* Subject participating in other research or clinical studies
* Subject for which stoma closure is scheduled before the end of the study
* A subject who, according to the investigator, has cognitive problems that prevent him or her from answering a questionnaire or for whom evaluation could be problematic.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoires Coloplast S.A.S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Meurette, MD
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Du Pays D'Aix
Aix-en-Provence, , France
Hotel Dieu
Angers, , France
Centre Hospitalier d'Arras
Arras, , France
Hopital de Mercy
Ars-Laquenexy, , France
Centre Hospitalier Henri Mondor
Aurillac, , France
Ch Henri Duffaut
Avignon, , France
Clinique Belharra
Bayonne, , France
Centre Hospitalier de Beauvais
Beauvais, , France
Hopital Jean Minjoz
Besançon, , France
Hopital La Cavale Blanche
Brest, , France
Hopital Cote de Nacre
Caen, , France
Centre Hospitalier de Douai
Cambrai, , France
Hopital Du Pays D Autan
Castres, , France
Hopital Manchester
Charleville-Mézières, , France
Centre Hospitalier General
Châteauroux, , France
Centre Hospitalier Du Cotentin Site de Cherbourg
Cherbourg Octeville, , France
Hopital Beaujon
Clichy, , France
Hopital Sud Francilien
Corbeil-Essonnes, , France
Centre Georges François Leclerc
Dijon, , France
Clinique Claude Bernard
Ermont, , France
Cabinet infirmier
Étrelles, , France
Centre Hospitalier Intercommunal Eure Seine
Évreux, , France
Cabinet Infirmier
Flins-sur-Seine, , France
Hopital Nord Ouest
Gleizé, , France
Centre Hospitalier de Gonesse
Gonesse, , France
Hopital Saint Louis
La Rochelle, , France
Hopital La Source
La Source, , France
Hopital Prive de L Estuaire
Le Havre, , France
Pole Sante Sud
Le Mans, , France
Centre Hospitalier Du Dr Schaffner
Lens, , France
Hopital Robert Boulin
Libourne, , France
Hopital Dupuytren
Limoges, , France
Hopital Saint Philibert
Lomme, , France
Hopital Nord
Marseille, , France
Hopital Alphonse Laverand
Marseille, , France
Hopital de La Conception
Marseille, , France
Polyclinique Du Val de Saone
Mâcon, , France
Centre Hospitalier Annecy Genevois Site Annecy
Metz-Tessy, , France
Hopital Lapeyronie
Montpellier, , France
Clinique St Augustin
Nantes, , France
CHU Hôtel-Dieu
Nantes, , France
Centre Hospitalier Georges Renon
Niort, , France
Hopital Caremeau
Nîmes, , France
Centre Hospitalier de Guingamp
Pabu, , France
Hopital Saint Louis
Paris, , France
Hopital Saint Antoine
Paris, , France
Hopital Saint Antoine
Paris, , France
Hopital Cochin
Paris, , France
Hopital Bichat Claude Bernard
Paris, , France
Hopital Europeen Georges Pompidou
Paris, , France
Hopital Tenon
Paris, , France
Centre Hospitalier Francois Mitterand
Pau, , France
Hopital Saint Jean
Perpignan, , France
Clinique Mutualiste de Pessac
Pessac, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Centre Hospitalier Universitaire La Miletrie
Poitiers, , France
Hopital Pontchaillou
Rennes, , France
Centre Hospitalier de Rochefort
Rochefort, , France
Hopital Charles Nicolle
Rouen, , France
Hopital Yves Le Foll
Saint-Brieuc, , France
Centre Hospitalier St Charles
Saint-Dié, , France
Cabinet infirmier
Saint-Hilaire-de-Riez, , France
Hopital Nord
Saint-Priest-en-Jarez, , France
Les Hopitaux Du Mont Blanc
Sallanches, , France
Centre Hospitalier de Salon de Provence
Salon-de-Provence, , France
Centre Hospitalier de Seclin/Carvin
Seclin, , France
Hopital Civil
Strasbourg, , France
Hopital Hautepierre
Strasbourg, , France
Centre Hospitalier de La Gespe
Tarbes, , France
Hopitaux Du Leman Site Thonon
Thonon-les-Bains, , France
Hopital Sainte Musse
Toulon, , France
Hopital Rangueil
Toulouse, , France
Hopital Des Hauts Clos
Troyes, , France
Centre Hospitalier General
Valence, , France
Polyclinique Vauban
Valenciennes, , France
Centre Hospitalier de Valenciennes
Valenciennes, , France
Hopitaux de Brabois
Vandœuvre-lès-Nancy, , France
Hopital Robert Schuman
Vantoux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A03232-53
Identifier Type: OTHER
Identifier Source: secondary_id
2018-A03232-53
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.